BioEnterprise competitors

Mr. Mazelsky was appointed President and Chief Executive Officer of IDEXX on October 23, 2019. Prior to his appointment, Mr. Mazelsky served as IDEXX's Interim President and Chief Executive Officer beginning on June 28, 2019. Prior to his appointment as Interim President and Chief Executive Officer, he was an Executive Vice President responsible for our North American Companion Animal Group Commercial Organization and key elements of the innovation portfolio, including our IDEXX VetLab® in-house diagnostics, Diagnostic Imaging, Veterinary Software and Services, Rapid Assay and Telemedicine lines of business. He joined IDEXX in August 2012 as Executive Vice President. Previously, Mr. Mazelsky was a Senior Vice President and General Manager from 2010 to 2012 of Computed Tomography, Nuclear Medicine and Radiation Therapy Planning at Philips Healthcare, a subsidiary of Royal Philips Electronics. Previously he held a series of other leadership roles with increasing responsibilities during his tenure at Philips beginning in 2001. Prior to joining Philips, Mr. Mazelsky was at Agilent Technologies, where he was an Executive in Charge from 2000 to 2002, leading the integration of Agilent’s Healthcare Group into Philips. He also served as a General Manager of the Medical Consumables Business Unit from 1997 to 2000 at Agilent Technologies. From 1988 to 1996, he was in a number of roles at Hewlett Packard in finance, marketing and business planning. Mr. Mazelsky holds a bachelor’s degree in mathematics from the University of Rochester and an M.B.A. from the University of Chicago.

Sherrie Perkins is a Co-Executive Director at ARUP Institute for Clinical & Experimental Pathology, Chief Executive Officer at ARUP Laboratories, and Head:Clinical Pathology at University of Utah Medical School. She has worked as Professor at University of Utah Medical School, Senior VP:Research & Development at ARUP Laboratories, and Chief Medical Officer at ARUP Laboratories. Sherrie studied at WASHINGTON UNIVERSITY and University of Miami.

Nancy Sandy is a Chief Operating Officer at Taconic Biosciences and Chief Executive Officer at Taconic Biosciences. She has worked as President at Taconic Biosciences. Nancy studied at NACUBO Market Value of University of Wisconsin Endowment Assets.